scispace - formally typeset
S

Satoru Kodama

Researcher at Niigata University

Publications -  212
Citations -  8038

Satoru Kodama is an academic researcher from Niigata University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 31, co-authored 188 publications receiving 6853 citations. Previous affiliations of Satoru Kodama include American Medical Association & University of Tsukuba.

Papers
More filters
Journal ArticleDOI

Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-analysis

TL;DR: In this article, a systematic literature search was conducted for observational cohort studies using MEDLINE (1966 to December 31, 2008) and EMBASE (1980 to December 30, 2008), which reported associations of baseline cardiorespiratory fitness with CHD events, CVD events, or all-cause mortality in healthy participants.
Journal ArticleDOI

Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis

TL;DR: There appears to exist a minimum exercise volume for a significant increase in HDL-C level, and exercise duration per session was the most important element of an exercise prescription.
Journal ArticleDOI

Association Between Serum Uric Acid and Development of Type 2 Diabetes

TL;DR: The current meta-analysis suggests that SUA level is positively associated with the development of type 2 diabetes regardless of various study characteristics.
Journal ArticleDOI

Alcohol Consumption and Risk of Atrial Fibrillation: A Meta-Analysis

TL;DR: This meta-analysis suggests that not consuming alcohol is most favorable in terms of AF risk reduction, and indicates that the AF risk increased with increasing levels of alcohol consumption.
Journal ArticleDOI

HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study

TL;DR: The predictive value for progression to diabetes assessed by HbA(1c) 5·7-6·4% was similar to that assessed by impaired fasting glucose alone, suggesting the two tests used together could efficiently target people who are most likely to develop diabetes and allow for early intervention.